Effects of the COVID-19 pandemic on the patients with diabetes mellitus healthcare, General Pueyrredon District, Argentina

Authors

  • Javier Remón Hospital Bernardo Houssay (PAMI), Mar del Plata, Provincia de Buenos Aires, Argentina
  • Sofía Guzmán Rodríguez Centro de Especialidades Médicas Ambulatorias (CEMA/Partido de General Pueyrredón), Mar del Plata, Provincia de Buenos Aires, Argentina
  • Adrián Ballejo Instituto Nacional de Epidemiología “Dr. Juan Héctor Jara” - Administración Nacional de Laboratorios e Institutos de Salud (ANLIS) “Dr. Carlos Malbrán”, Mar del Plata, Provincia de Buenos Aires, Argentina
  • María Fernanda Aguirre Instituto Nacional de Epidemiología “Dr. Juan Héctor Jara” - Administración Nacional de Laboratorios e Institutos de Salud (ANLIS) “Dr. Carlos Malbrán”, Mar del Plata, Provincia de Buenos Aires, Argentina
  • María Eugenia De San Martín Instituto Nacional de Epidemiología “Dr. Juan Héctor Jara” - Administración Nacional de Laboratorios e Institutos de Salud (ANLIS) “Dr. Carlos Malbrán”, Mar del Plata, Provincia de Buenos Aires, Argentina
  • Micaela Azucena Azucena Gauto Instituto Nacional de Epidemiología “Dr. Juan Héctor Jara” - Administración Nacional de Laboratorios e Institutos de Salud (ANLIS) “Dr. Carlos Malbrán”, Mar del Plata, Provincia de Buenos Aires, Argentina
  • Manuel Toñanes Centro de Especialidades Médicas Ambulatorias (CEMA/Partido de General Pueyrredón), Mar del Plata, Provincia de Buenos Aires, Argentina
  • María Laura Ruiz Centro de Especialidades Médicas Ambulatorias (CEMA/Partido de General Pueyrredon), Mar del Plata, Provincia de Buenos Aires, Argentina
  • Julia Maxwell Instituto Nacional de Epidemiología “Dr. Juan Héctor Jara” - Administración Nacional de Laboratorios e Institutos de Salud (ANLIS) “Dr. Carlos Malbrán”, Mar del Plata, Provincia de Buenos Aires, Argentina
  • María Luz S Luz Sánchez Instituto Nacional de Epidemiología “Dr. Juan Héctor Jara” - Administración Nacional de Laboratorios e Institutos de Salud (ANLIS) “Dr. Carlos Malbrán”, Mar del Plata, Provincia de Buenos Aires, Argentina
  • María Jimena Marro Instituto Nacional de Epidemiología “Dr. Juan Héctor Jara” - Administración Nacional de Laboratorios e Institutos de Salud (ANLIS) “Dr. Carlos Malbrán”, Mar del Plata, Provincia de Buenos Aires, Argentina

Keywords:

Coronavirus Infections, Diabetes Mellitus, Health Services Coverage, Health Inequalities, Argentina

Abstract

INTRODUCTION: The COVID-19 pandemic led to the adoption of confinement measures with impact on the control of diabetes mellitus (DM). The aim was to assess the effect of the pandemic on the care of people with DM in the public and private health subsectors of General Pueyrredon District (PGP). The primary endpoints were glycosylated hemoglobin (HbA1c) and metabolic control, and the secondary were fasting plasma glucose, body mass index (BMI), triglycerides, cholesterol, medical visits, hospitalization, ophthalmoscopy and albumin-to-creatinine ratio. Differences with a p-value. RESULTS: A total of 327 participants were included (51.7% from the public subsector). Median HbA1c increased from 8.1% (interquartile range [IQR] 2.7) to 8.8% (IQR 2.8). The pandemic along with the public subsector healthcare and incomplete DM treatment were independent predictors of the HbA1c increase; while insulin treatment was a predictor of glycemic control decrease. DISCUSSION: The pandemic had a negative impact on DM medical care, which highlights inequalities in the subsectors of the healthcare system.

Downloads

Download data is not yet available.

Published

28-06-2024

How to Cite

Remón, J., Guzmán Rodríguez, S., Ballejo, A., Aguirre, M. F., De San Martín, M. E., Azucena Gauto, M. A., … Marro, M. J. (2024). Effects of the COVID-19 pandemic on the patients with diabetes mellitus healthcare, General Pueyrredon District, Argentina. Revista Argentina De Salud Pública, 16, e124. Retrieved from https://rasp.msal.gov.ar/index.php/rasp/article/view/854